Your browser doesn't support javascript.
loading
Uterine transposition in a patient with vulvar cancer.
Laufer, Joel; Scasso, Santiago; Kimelman, Dana; Olmedo, Clara; Bentancor, Valeria; Soust, Anne; Sotero, Gonzalo; Ribeiro, Reitan.
Afiliação
  • Laufer J; Department of Gynecology C, Universidad de la República, Montevideo, Uruguay.
  • Scasso S; Department of Gynecology, British Hospital, Montevideo, Uruguay.
  • Kimelman D; Oncofertility Program. Hospital Pereira Rossell, ASSE, Montevideo, Uruguay.
  • Olmedo C; Department of Gynecology C, Universidad de la República, Montevideo, Uruguay.
  • Bentancor V; Department of Gynecology C, Universidad de la República, Montevideo, Uruguay.
  • Soust A; Department of Gynecology C, Universidad de la República, Montevideo, Uruguay.
  • Sotero G; Department of Gynecology C, Universidad de la República, Montevideo, Uruguay.
  • Ribeiro R; Department of Surgical Oncology, Erasto Gaertner Hospital, Curitiba, Brazil.
Gynecol Oncol Rep ; 52: 101337, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38404910
ABSTRACT

Objective:

To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of the uterus to the upper abdomen, outside of the scope of radiation was performed to preserve fertility and ovarian function. After the end of radiotherapy, the uterus was repositioned into the pelvis.Main Outcome

Measure:

Uterine and ovarian function preservation.

Result:

The patient recovered her menstrual cycles spontaneously 1 month after the reimplantation and exhibited normal variation in ovarian hormones.Twelve months after the surgery, the uterus was normal and there was no sign of recurrent disease.

Conclusion:

Uterine transposition might represent a valid option for fertility preservation in women who require pelvic radiotherapy. However, studies that assess its viability, effectiveness, and safety are required.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Uruguai País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Uruguai País de publicação: Holanda